Ovarian Cancer News and reporting on ovarian cancer. Oct 7, 2021 Genoox, Aspira Women's Health Partner to Develop New MDx Technologies Sep 28, 2021 Newly Combined Finnish Firm Developing POC Instrument Integrating Molecular, Immunoassay Testing Premium Aug 9, 2021 Qiagen, OncXerna Therapeutics Ink Companion Dx Development, Technology-Licensing Deal Aug 3, 2021 Burning Rock Biotech, Impact Therapeutics Partner on CDx for PARP Inhibitor Senaparib May 14, 2021 Aspira Women's Health Working to Diversify Offerings Beyond OVA1 Premium Feb 19, 2021 AmoyDx, AstraZeneca Strike Ovarian Cancer Companion Diagnostic Alliance Nov 19, 2020 Aspira Collaborating With Baylor Genetics on Ovarian Cancer Early Detection Test Nov 16, 2020 InterVenn Biosciences Raises $34M in Series B Round to Commercialize Ovarian Cancer Test Nov 16, 2020 Myriad Genetics Expands MyChoice CDx Access Through Partnerships in Europe, China Oct 27, 2020 FDA Approves Foundation Medicine Liquid Biopsy Test as CDx for Three Targeted Therapies Sep 24, 2020 Exact Sciences Stock Soars on New Data Around Pan-Cancer Liquid Biopsy Test Jul 22, 2020 Devyser Gains CE Mark for NGS Hereditary Breast and Ovarian Cancer Test Jul 17, 2020 BRCA1/2 Population Screening Predicted to be Cost-Effective in Countries With Different Income Levels Jun 17, 2020 U of Kansas Inkjet Printing Approach Aims to Speed Development of Exosome-Based Microfluidic Tests May 22, 2020 Local Coverage Determinations Roundup: Aspira Labs, Fujirebio Diagnostics May 11, 2020 FDA Approves Lynparza/Avastin With Myriad Genetics CDx for Platinum-Sensitive Ovarian Cancer Apr 30, 2020 GSK Gets Broad Zejula Indication in Ovarian Cancer; FDA Deems Myriad Genetics' Test Complementary Apr 6, 2020 Myriad Genetics BRCA Test to be Reimbursed in Japan Feb 21, 2020 Immune Response Marker Has Potential to Improve Ovarian Cancer Screening, Study Says Premium Feb 11, 2020 Myriad Files sPMA With FDA for Test to ID Best Responders to Lynparza, Avastin Combination Load More Breaking News Rady Children's, PlumCare RWE Partner to Expand WGS-Based Newborn Screening Program to Greece Roche Gets CE Mark for New Version of Rapid Test for Antibodies Against SARS-CoV-2 Broader Market Drags 360Dx Top 30 Down in September Olive Diagnostics Nabs CE Mark for Optical Urinalysis Device Top Five Articles on 360Dx Last Week: Congress and VALID Act; FDA Updates EUA Policy; and More In Brief This Week: Becton Dickinson, Bionano, Yourgene, More
